» » Assessing Neurotoxicity of Drugs of Abuse (Nida Research Monograph ; 136)

Download Assessing Neurotoxicity of Drugs of Abuse (Nida Research Monograph ; 136) fb2

by National Institute on Drug Abuse,Lynda Erinoff
Download Assessing Neurotoxicity of Drugs of Abuse (Nida Research Monograph ; 136) fb2
  • Author:
    National Institute on Drug Abuse,Lynda Erinoff
  • ISBN:
    0160429129
  • ISBN13:
    978-0160429125
  • Genre:
  • Publisher:
    United States Govt Printing Office; First Edition edition (November 1, 1993)
  • Pages:
    281 pages
  • Language:
  • FB2 format
    1347 kb
  • ePUB format
    1953 kb
  • DJVU format
    1730 kb
  • Rating:
    4.5
  • Votes:
    429
  • Formats:
    mbr doc azw rtf


Alcohol Amphetamines Bath Salts Brain and Addiction Club Drugs Cocaine Drug Overdoses in Youth Emerging Drugs Fentanyl GHB Hallucinogens Heroin Illegal Drugs Illicit Opioids Illicit Stimulants Inhalants K2/Spice Kratom LSD (Acid) Marijuana MDMA (Ecstasy) Methamphetamine Naloxone Nicotine Opioids Other Drugs Over-the-Counter Medications Pain Medication PCP (Phencyclidine) Prescription Drugs Prescription Stimulants Ritalin Salvia Sedatives Steroids (Anabolic) Tobacco.

Neurotoxicity and Drugs of Abuse: Cannabinoid Interaction With Brain .

Neurotoxicity and Drugs of Abuse: Cannabinoid Interaction With Brain Glucocorticoid Receptors. Nitric Oxide as a Mediator of Neurotoxicity. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857.

Assessing Neurotoxicity of Drugs of Abuse AUTHOR Lynda Erinoff, P.

Assessing Neurotoxicity of Drugs of Abuse. Department of Health and Human Services, Public Health Service, National Institutes of Health. Assessing Neurotoxicity of Drugs of Abuse. AUTHOR Lynda Erinoff, P.

The National Institute on Drug Abuse has obtained permission from. Department of Health and Human Services, Public Health Service, National Institutes of Health

The National Institute on Drug Abuse has obtained permission from. Elsevier Biomedical as were associations with phenotypic markers such as the HLA type. Behavioral Treatments for Drug Abuse and.

NIDA (National Institute on Drug Abuse). bweiner hazeldenbettyford 136. ark:/13960/t0ns7k460.

Start by marking Assessing Neurotoxicity Of Drugs Of Abuse as Want to Read .

Start by marking Assessing Neurotoxicity Of Drugs Of Abuse as Want to Read: Want to Read savin. ant to Read.

This 1982 national survey on drug abuse is the seventh in a series of surveys since 1971 sponsored by the National Institute on Drug Abuse. To investigate the current prevalence of drug abuse in a nationwide sample, 5,624 randomly selected Americans (aged 12 and older) were personally interviewed in their homes using a specially designed answer sheet to assure privacy. An analysis of the results showed a reversal of the upward trends in drug abuse charted in surveys through the 1970's.

The al addiction dichotomy is reflected in the Controlled Substances Act's criteria for drug scheduling.

MDMA Neurotoxicity: New Data, New Risk Analysis Rick Doblin. In: Assessing Neurotoxicity of Drugs of Abuse, Erinoff, . E. National Institute on Drug Abuse Monograph 136, p. 88-212, Washington, DC, US Government Printing Office, 1993.

The institute has conducted an in-depth study of addiction according to its biological, behavioral and social components.